SCHEMBL22479947

SCHEMBL22479947

CC1(C)C=CC2=C(C=N1)NC(=O)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22479922 0.74 — —
SCHEMBL21349639 0.69 MEN1 (0.31) —
SCHEMBL21349642 0.62 — —
SCHEMBL14421622 0.62 — —
SCHEMBL29319531 0.62 — —
SCHEMBL22479946 0.60 — —
SCHEMBL21660596 0.58 CRBN (0.37) —
SCHEMBL22845254 0.57 — —
SCHEMBL1509853 0.53 — —
SCHEMBL14360447 0.52 MAPT (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3943488-A1 SUBSTITUTED HETEROCYCLIC AMIDE COMPOUND AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Genfleet Therapeutics (Shanghai) Inc. (CN) 2022-01-26 — — EP disclosed
WO-2020192562-A1 SUBSTITUTED HETEROCYCLIC AMIDE COMPOUND AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 劲方医药科技(上海)有限公司 2020-10-01 — — WO disclosed
Send feedback